interaction records 54 assistance programs 55 0 personal data stored

Recorded fact · program.covers_drug

program.covers_drug for genentech-access-solutions

One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 58828f71 resolves to.

The record

Fact id58828f71b00f3d13fc66d50b
Entityprogram: genentech-access-solutions
Fieldprogram.covers_drug
Sourcewww.gene.com
Read on2026-11-08T21:45:00.000Z
Source versionbrowser-read-2026-11-08
Methodpage-read
Verificationverified
Licencefacts only (numbers, dates, statuses, hashes); no prose copied; attribution by URL
Edition2026-11, Merkle root 006ab9a329709cbe...

The verifying quote

The Genentech medicines supported by the Genentech Patient Foundation are: Actemra® (tocilizumab)* Activase® (alteplase) Alecensa® (alectinib)

Shown with dashes as hyphens. SHA-256 of the exact stored quote: 660d554405b4c2a9e9f81a8b328797d39652c022c965cd3c55db47548a02e33a.

The value

{
 "programName": "Genentech Patient Foundation",
 "sponsor": "Genentech",
 "listKind": "Our Participating Medicines",
 "asOf": null,
 "drugs": [
  {
   "name": "Actemra",
   "note": "stops accepting new enrollments effective January 1, 2027; all Foundation support ends December 31, 2027"
  },
  {
   "name": "Activase"
  },
  {
   "name": "Alecensa"
  },
  {
   "name": "Avastin"
  },
  {
   "name": "Cathflo Activase"
  },
  {
   "name": "Columvi"
  },
  {
   "name": "Cotellic",
   "note": "stops accepting new enrollments effective January 1, 2027; all Foundation support ends December 31, 2027"
  },
  {
   "name": "Enspryng"
  },
  {
   "name": "Erivedge"
  },
  {
   "name": "Evrysdi"
  },
  {
   "name": "Gazyva"
  },
  {
   "name": "Hemlibra"
  },
  {
   "name": "Herceptin"
  },
  {
   "name": "Herceptin Hylecta"
  },
  {
   "name": "Itovebi"
  },
  {
   "name": "Kadcyla"
  },
  {
   "name": "Lucentis"
  },
  {
   "name": "Lunsumio"
  },
  {
   "name": "Ocrevus"
  },
  {
   "name": "Ocrevus Zunovo"
  },
  {
   "name": "Perjeta"
  },
  {
   "name": "Phesgo"
  },
  {
   "name": "PiaSky"
  },
  {
   "name": "Polivy"
  },
  {
   "name": "Pulmozyme"
  },
  {
   "name": "Rituxan"
  },
  {
   "name": "Rituxan Hycela"
  },
  {
   "name": "Rozlytrek"
  },
  {
   "name": "Susvimo"
  },
  {
   "name": "Tecentriq"
  },
  {
   "name": "Tecentriq Hybreza"
  },
  {
   "name": "TNKase"
  },
  {
   "name": "Vabysmo"
  },
  {
   "name": "Venclexta"
  },
  {
   "name": "Xolair"
  },
  {
   "name": "Zelboraf",
   "note": "stops accepting new enrollments effective January 1, 2027; all Foundation support ends December 31, 2027"
  }
 ]
}

SHA-256 of the exact stored value: d5ab664a416a6d992cdece412a0cc5945ec6ca9ef403bae47f35d519998625df.

This fact as data (JSON) · Check an answer against its receipt · Licence

Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.